Try it
Pharmacology · General pharmacology: non-competitive antagonism
Sample itemPhenoxybenzamine binds covalently to alpha adrenoceptors. What happens to the noradrenaline dose-response curve after adequate dosing?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. The maximal response is depressed and cannot be restored by higher noradrenaline doses
Irreversible binding removes functional receptors, so even very high agonist concentrations cannot produce the original maximal effect. This is non-competitive (insurmountable) antagonism.
Option by option
A. The maximal response is depressed and cannot be restored by higher noradrenaline doses (correct)
Correct. Receptor loss lowers the maximum, which cannot be overcome.
B. The curve shifts right in parallel and the maximum is preserved
A parallel shift with preserved maximum is competitive antagonism.
C. The curve shifts left
A left shift would suggest increased sensitivity, not antagonism.
D. Potency increases while efficacy is unchanged
Antagonism reduces effect and does not raise potency.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?